At the time of writing, Plus Therapeutics Inc [PSTV] stock is trading at $0.61, up 1.96%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PSTV shares have gain 24.90% over the last week, with a monthly amount glided 12.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Plus Therapeutics Inc [NASDAQ: PSTV] stock has seen the most recent analyst activity on September 03, 2025, when D. Boral Capital upgraded its rating to a Buy but kept the price target unchanged to $5 for it. Previously, D. Boral Capital started tracking the stock with Buy rating on March 17, 2025, and set its price target to $9. On January 25, 2021, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $8 on the stock. Maxim Group started tracking the stock assigning a Buy rating and suggested a price target of $6 on October 16, 2020.
For the past year, the stock price of Plus Therapeutics Inc fluctuated between $0.16 and $2.31. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Plus Therapeutics Inc [NASDAQ: PSTV] shares were valued at $0.61 at the most recent close of the market. An investor can expect a potential return of 227.87% based on the average PSTV price forecast.
Analyzing the PSTV fundamentals
According to Plus Therapeutics Inc [NASDAQ:PSTV], the company’s sales were 5.26M for trailing twelve months, which represents an -4.05% plunge. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at -2.32%, Pretax Profit Margin comes in at -5.33%, and Net Profit Margin reading is -5.33%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is 3.36 and Total Capital is -1.78. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5970 points at the first support level, and at 0.5840 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6260, and for the 2nd resistance point, it is at 0.6420.
Ratios To Look Out For
It is important to note that Plus Therapeutics Inc [NASDAQ:PSTV] has a current ratio of 1.27. Further, the Quick Ratio stands at 1.27, while the Cash Ratio is 0.98. Considering the valuation of this stock, the price to sales ratio is 15.94, the price to book ratio is 15.89.
Transactions by insiders
Recent insider trading involved Sims Andrew John Hugh MacIntyr, Chief Financial Officer, that happened on Nov 04 ’25 when 20000.0 shares were purchased. Director, Lenk Robert P completed a deal on Aug 22 ’25 to buy 0.11 million shares. Meanwhile, Director Petersen Greg bought 36666.0 shares on May 15 ’25.
